DK1648413T3 - Farmaceutiske præparater af kortvirkende sedativt sövndyssende middel - Google Patents

Farmaceutiske præparater af kortvirkende sedativt sövndyssende middel

Info

Publication number
DK1648413T3
DK1648413T3 DK04757141T DK04757141T DK1648413T3 DK 1648413 T3 DK1648413 T3 DK 1648413T3 DK 04757141 T DK04757141 T DK 04757141T DK 04757141 T DK04757141 T DK 04757141T DK 1648413 T3 DK1648413 T3 DK 1648413T3
Authority
DK
Denmark
Prior art keywords
short
pharmaceutical preparations
spraying agent
acting sedative
sedative sleep
Prior art date
Application number
DK04757141T
Other languages
Danish (da)
English (en)
Inventor
Thomas E Jenkins
Jennifer Bolton
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Application granted granted Critical
Publication of DK1648413T3 publication Critical patent/DK1648413T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK04757141T 2003-07-23 2004-07-21 Farmaceutiske præparater af kortvirkende sedativt sövndyssende middel DK1648413T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48955903P 2003-07-23 2003-07-23
PCT/US2004/023275 WO2005009420A2 (fr) 2003-07-23 2004-07-21 Compositions pharmaceutiques d'un agent hypnotique sedatif a action breve

Publications (1)

Publication Number Publication Date
DK1648413T3 true DK1648413T3 (da) 2010-01-11

Family

ID=34102897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04757141T DK1648413T3 (da) 2003-07-23 2004-07-21 Farmaceutiske præparater af kortvirkende sedativt sövndyssende middel

Country Status (11)

Country Link
US (2) US7790766B2 (fr)
EP (1) EP1648413B1 (fr)
AT (1) ATE444734T1 (fr)
CY (1) CY1109657T1 (fr)
DE (1) DE602004023509D1 (fr)
DK (1) DK1648413T3 (fr)
ES (1) ES2332514T3 (fr)
PL (1) PL1648413T3 (fr)
PT (1) PT1648413E (fr)
SI (1) SI1648413T1 (fr)
WO (1) WO2005009420A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546453B2 (en) * 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
AU2007240317B2 (en) * 2006-04-20 2012-11-29 Amgen Inc. Stable emulsion formulations
AU2011258940B2 (en) * 2010-05-13 2014-05-29 Astrazeneca Ab Injectable emulsion of sedative hypnotic agent
CN105106115A (zh) * 2015-10-10 2015-12-02 北京蓝丹医药科技有限公司 一种稳定的丙泮尼地脂肪乳

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086978A (en) 1960-05-06 1963-04-23 Bayer Ag 3-methoxy-4-carbamidomethoxy-phenylacetic acid esters
DE1134981B (de) 1960-05-06 1962-08-23 Bayer Ag Verfahren zur Herstellung von N-substituierten 3-Methoxy-4-carbamidomethoxyphenylessigsaeurealkyl- und alkenylestern
NL284933A (fr) 1961-10-31
NL286944A (fr) 1961-12-20
US3510559A (en) 1964-01-10 1970-05-05 Geigy Chem Corp 2-alkoxyphenoxy-acetamides as anesthetics agents
CH432494A (de) 1964-01-10 1967-03-31 Geigy Ag J R Verfahren zur Herstellung neuer Aryloxyessigsäureamide
US3511877A (en) 1964-02-11 1970-05-12 Geigy Chem Corp Phenoxyacetic acid diethylamides
DE1249851B (de) 1964-02-11 1967-09-14 J R Geigy A G Basel (Schweiz) Morel Ariesheim (Schweiz) j Verfahren zur Herstellung neuer Phenoxyessigsäure amide
DE1518819B1 (de) 1965-04-03 1969-12-04 Basf Ag Loesungsvermittler fuer pharmazeutische Zwecke
US4798846A (en) 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
GB1571395A (en) 1976-07-12 1980-07-16 Delmar Chem Substituted phenyl acetic acid esters
JPS5699440A (en) 1980-01-11 1981-08-10 Ube Ind Ltd Preparation of 3-alkoxy-4-hydroxyphenylacetic acid
EP0054635B1 (fr) * 1980-12-23 1985-02-13 Dr. Franz Köhler Chemie GmbH Solution protectrice pour le coeur et le rein et procédé pour sa préparation
JPS6038343A (ja) 1983-08-11 1985-02-27 Mitsubishi Petrochem Co Ltd フエニル酢酸誘導体の製造方法
DE3339236A1 (de) 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
US4918092A (en) 1983-12-21 1990-04-17 Merck Frosst Canada, Inc. Leukotriene antagonists
IT1204778B (it) 1986-02-04 1989-03-10 Mazzarella Basilio Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
US5092838A (en) 1989-11-30 1992-03-03 Baxter International Inc. Histidine buffered peritoneal dialysis solution
EP0443609B2 (fr) * 1990-02-23 2002-07-24 Tomoegawa Paper Co. Ltd. Méthode et appareil de polymérisation en suspension
US5242944A (en) 1991-06-20 1993-09-07 Korea Research Institute Of Chemical Technology Phenylacetamide derivatives and pharmaceutical compositions thereof
GB9405593D0 (en) 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US20020173547A1 (en) 1994-03-22 2002-11-21 Jones Christopher Buchan Pharmaceuticals compositions
ZA962214B (en) 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
CO4810371A1 (es) 1998-02-10 1999-06-30 Gensia Sicor Inc Composicion de propofol que contiene sulfito
US6028108A (en) 1998-10-22 2000-02-22 America Home Products Corporation Propofol composition comprising pentetate
US6140373A (en) 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6140374A (en) 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6177477B1 (en) 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
AU6689601A (en) 2000-06-16 2002-01-02 Rtp Pharma Inc Improved injectable dispersions of propofol
DK1509492T3 (da) 2002-01-25 2011-11-28 Theravance Inc Sedative hypnotiske midler med kort virkningsvarighed til anæstesi og sedation

Also Published As

Publication number Publication date
WO2005009420A3 (fr) 2005-03-03
EP1648413B1 (fr) 2009-10-07
US20100076079A1 (en) 2010-03-25
HK1090841A1 (en) 2007-01-05
PL1648413T3 (pl) 2010-03-31
ES2332514T3 (es) 2010-02-08
US20050020674A1 (en) 2005-01-27
ATE444734T1 (de) 2009-10-15
US7981931B2 (en) 2011-07-19
EP1648413A2 (fr) 2006-04-26
WO2005009420A2 (fr) 2005-02-03
DE602004023509D1 (de) 2009-11-19
US7790766B2 (en) 2010-09-07
SI1648413T1 (sl) 2010-01-29
CY1109657T1 (el) 2014-08-13
PT1648413E (pt) 2009-12-28

Similar Documents

Publication Publication Date Title
NO2020031I1 (no) kobimetinib, inklusive farmasøytisk akseptable salter og solvater, særlig kobimetinib hemifumarat
CY1118179T1 (el) Φαρμακευτικη συνθεση
NO20070785L (no) Sammensetninger for levering av svaert vannloselige medikamenter.
CY1112487T1 (el) Βραχειας-δρασης ηρεμιστικοι υπνωτικοι παραγοντες για αναισθησια και καταστολη
CY1109010T1 (el) γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ
ATE382057T1 (de) Stabile formulierung von modifiziertem glp-1
MXPA04008068A (es) Metodo para administrar moleculas de glp-1.
CY1111197T1 (el) Tριαζολες χρησιμες ως αναστολεις πρετεϊνικων κινασων
TW200716157A (en) Pharmaceutical formulations and methods of treatment using the same
ATE498395T1 (de) Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
UY28342A1 (es) Nuevos compuestos
ECSP088296A (es) Compuestos terapéuticos
TW200728285A (en) Diacylindazole derivatives as inhibitors of lipases and phospholipases
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
DK1608346T3 (da) Lægemiddeltilförselssammensætninger af alfa-hydroxysyreester og fremgangsmåder til anvendelse heraf
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
MEP34308A (en) Oral formulations of cladribine
CY1109657T1 (el) Φαρμακευτικες συνθεσεις ηρεμιστικου υπνωτικου μεσου ταχειας δρασης
WO2007121471A3 (fr) Agents d'administration des éthers dialkyliques
BRPI0516464A (pt) formulação farmacêutica, método para a preparação de um produto farmacêutico, e, uso de uma formulação farmacêutica
IL151815A0 (en) Drug combination for the treatment of headache comprising a non-steroidal anti-inflammatory drug
IL174265A0 (en) Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
BRPI0515533B8 (pt) formulação farmacêutica estável para inibir urocinase
CY1115063T1 (el) Μεθοδος και συνθεση για τη θεραπεια φλεγμονωδων διαταραχων
HK1093024A (en) Methods and compositions for the oral administration of prodrugs of proton pump inhibitors